HIV Prevention During Chemsex

NCT03956758 | Withdrawn

• 1 other identifier: RECHMPL19_0233
• Study Type: observational
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

In 2016, the number of discoveries of HIV seropositivity is estimated at about 6000 in France. Men who have sex with men (MSM) account for 44% of these infections (68% in the Occitanie region). For the past ten years, there have been new practices of sexual drug use among MSM referred to as Chemsex. These practices expose to sexual risks but also to those related to the consumption of drugs making this population more at risk to get infectious contaminations. In the "PREVAGAY study" conducted in Montpellier in 2015, about 30% of MSM included said they had consumed at least one psychoactive product before or during sex during the last 12 months. In addition, this percentage was significantly higher among HIV-positive men (51% versus 24% of HIV-negative men) and 1% (N = 9) had practiced Slam (Sexual Injection). The results of this study also showed that PreP (Prophylaxis Pre-exposure to HIV) was known by 52% of MSM included and 4% (N = 4) had already used it in the last 12 months. Several observations are needed: many ChemSex users do not use the PreP despite the fact that its effectiveness has been proven in many studies. The social sciences have been studying the HIV epidemic since its emergence. In the era of HIV chronic disease, the sociologist Gabriel Girard wanted to question the pessimistic observation of epidemiological studies in his thesis work. Some contradictory logics explains this epidemiology of HIV which is maintained, particularly in Montpellier despite the arrival of the PreP. The main objective of our study is to explore the reflexive logic structuring the report to HIV prevention by MSM practicing ChemSex in Montpellier, in the context of the appearance and dissemination of the PreP.

Conditions

Men Having Sex With Other Men

Keywords

MSM; Chemical sex; HIV prevention; HIV pre-exposure prophylaxis

Outcome Measures

Primary Outcomes (1)

• report to HIV

  report to HIV contamination during Chemsex

  1 day

Interventions

Semi-directed interview OTHER

Semi-directed interview on ChemSex practice

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: male
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

MSM living in Montpellier with negative HIV status, having at least one sexual intercourse under drug use during the last 12 months

You may qualify if:

• Men who have sex with men (MSM)
• living in Montpellier
• using chemsex drugs at least one during sexual intercourse

You may not qualify if:

• under 18 years
• seropositive HIV

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Officials

• Clemence GIRARD, Medical intern

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 16, 2019
• First Posted: May 21, 2019
• Study Start: April 1, 2019
• Primary Completion: April 1, 2019
• Study Completion: April 1, 2019
• Last Updated: November 19, 2019

Record last verified: 2019-11